TAM
GHDX

Tocqueville Asset Management’s Genomic Health, Inc. GHDX Stock Holding History

Tocqueville Asset Management’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-8,900
Closed -$234K – 1830
2014
Q1 		$234K Buy
8,900
+1,600
+22% +$45.9K ﹤0.01% 766
2013
Q4 		$214K Sell
7,300
-900
-11% -$28.6K ﹤0.01% 795
2013
Q3 		$251K Sell
8,200
-2,700
-25% -$90.3K ﹤0.01% 826
2013
Q2 		$346K Buy
+10,900
New +$358K ﹤0.01% 735

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Tocqueville Asset Management's GHDX Position: Q2 2014 in Review

Tocqueville Asset Management sold out of Genomic Health, Inc. (GHDX) in Q2 2014, closing a stake of 8,900 shares — an estimated $234K sold.

Tocqueville Asset Management first reported a position in GHDX in Q2 2013 and held it in 4 quarters. The position peaked at $346K in Q2 2013. 112 funds tracked by Wall St. Rank hold GHDX as of Q2 2014.

  • Tocqueville Asset Management reported no remaining Genomic Health, Inc. position as of Q2 2014 after selling out during the quarter.
  • Tocqueville Asset Management sold 8,900 Genomic Health, Inc. shares in Q2 2014, an estimated $234K.
  • Tocqueville Asset Management first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 4 quarters.
  • Tocqueville Asset Management's Genomic Health, Inc. position peaked at $346K in Q2 2013.
  • 112 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2014.

Based on Tocqueville Asset Management's 13F filing for Q2 2014, filed 30 Jul 2014.